Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,256,631 papers from all fields of science
Search
Sign In
Create Free Account
Bilateral Prophylactic Oophorectomy
Surgical removal of both non-diseased ovaries with the goal of preventing ovarian carcinoma.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Endocrine system
Female Reproductive System
Genitourinary system
Gonadal structure
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
T. Friebel
,
S. Domchek
,
+16 authors
T. Rebbeck
Clinical Breast Cancer
2007
Corpus ID: 5098926
BACKGROUND Women with BRCA1 or BRCA2 (BRCA1/2) mutations can reduce cancer incidence and mortality by using bilateral…
Expand
Highly Cited
2005
Highly Cited
2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
T. Rebbeck
,
T. Friebel
,
+16 authors
B. Weber
Journal of Clinical Oncology
2005
Corpus ID: 25628067
PURPOSE Bilateral prophylactic oophorectomy (BPO) is widely used for cancer risk reduction in women with BRCA1/2 mutations. Many…
Expand
Highly Cited
2005
Highly Cited
2005
Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
T. V. van Sprundel
,
M. Schmidt
,
+5 authors
R. Tollenaar
British Journal of Cancer
2005
Corpus ID: 18659117
The clinical outcome of contralateral prophylactic mastectomy (CPM) in women with a BRCA1 or BRCA2 mutation and a personal…
Expand
Review
2005
Review
2005
Additional salpingectomy after previous prophylactic oophorectomy in high-risk women: sense or nonsense?
R. I. Olivier
,
Lottie A C Lubsen-Brandsma
,
H. V. van Boven
,
M. van Beurden
Gynecologic Oncology
2005
Corpus ID: 40877042
Highly Cited
2004
Highly Cited
2004
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
T. Rebbeck
,
T. Friebel
,
+10 authors
B. Weber
Journal of Clinical Oncology
2004
Corpus ID: 30794213
PURPOSE Data on the efficacy of bilateral prophylactic mastectomy for breast cancer risk reduction in women with BRCA1 and BRCA2…
Expand
Highly Cited
2003
Highly Cited
2003
Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.
M. Schwartz
,
Elizabeth Kaufman
,
+5 authors
C. Lerman
Journal of Clinical Oncology
2003
Corpus ID: 22086154
PURPOSE Despite the widespread availability of genetic testing for BRCA1/BRCA2 mutations, little is known about the impact of…
Expand
Highly Cited
2002
Highly Cited
2002
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
T. Rebbeck
,
H. Lynch
,
+9 authors
B. Weber
New England Journal of Medicine
2002
Corpus ID: 39377533
BACKGROUND Data concerning the efficacy of bilateral prophylactic oophorectomy for reducing the risk of gynecologic cancer in…
Expand
Review
2000
Review
2000
Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.
T. Rebbeck
Journal of Clinical Oncology
2000
Corpus ID: 5617807
2000
2000
Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.
T. Rebbeck
European Journal of Cancer
2000
Corpus ID: 26906063
Highly Cited
1999
Highly Cited
1999
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
T. Rebbeck
,
A. Levin
,
+12 authors
B. Weber
Journal of the National Cancer Institute
1999
Corpus ID: 32690926
BACKGROUND The availability of genetic testing for inherited mutations in the BRCA1 gene provides potentially valuable…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE